Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib

The combination of immune-checkpoint blockade (ICB) and lenvatinib has demonstrated robust clinical effects that are superior to those of monotherapies, but the synergistic anti-tumor mechanisms remain unclear. Exploring the synergistic molecular mechanisms and early identifying potential applicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yuting, Jin, Jiangtao, Du, Qi, Hu, Min, Wei, Yuhan, Wang, Miao, Li, Hongzhong, Li, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458708/
https://www.ncbi.nlm.nih.gov/pubmed/34568339
http://dx.doi.org/10.3389/fcell.2021.730240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458708/
https://www.ncbi.nlm.nih.gov/pubmed/34568339
http://dx.doi.org/10.3389/fcell.2021.730240

Ejemplares similares